Resultados del tratamiento mínimamente invasivo de insuficiencia crónica de vena safena en pacientes de 20 a 70 años atendidos en el Hospital Naval Sur en el periodo 2023 a 2025.

Abstract

Introduction: Chronic venous insufficiency (CVI) of the great saphenous vein is a common condition that affects quality of life and may progress to severe complications. In recent years, minimally invasive techniques have progressively replaced conventional surgery due to their effectiveness and lower morbidity. Objective: To evaluate the clinical and ultrasound outcomes of minimally invasive treatment for chronic venous insufficiency of the great saphenous vein in patients treated at Hospital Naval Sur during the period 2023–2025. Methods: Observational, descriptive, retrospective, and cross-sectional study including 543 patients aged 20 to 70 years. Data were collected from medical records and analyzed using descriptive statistics with IBM SPSS version 26. Sociodemographic variables, CEAP classification, type of treatment, clinical evolution (VCSS), ultrasound outcomes, and complications were assessed. Results: There was a predominance of females (61.1%) and urban origin (69.4%), with a mean age of 48.9 ± 11.7 years. The most frequent CEAP stages were C2 (44.6%) and C3 (27.8%). Radiofrequency was the most commonly used treatment (41.4%), followed by endovenous laser (33.9%) and sclerotherapy (18.6%). Clinical improvement was observed in 86.7% of patients, and complete venous closure in 89.5%. A total of 87.1% had no complications; the most frequent were mild pain (6.4%) and ecchymosis (4.2%). Conclusion: Minimally invasive techniques demonstrated high clinical and ultrasound effectiveness with a low complication profile, representing a safe and effective alternative for the management of chronic venous insufficiency of the great saphenous vein.